Biogen Inc (BIIB)
193.10
-1.13
(-0.58%)
USD |
NASDAQ |
Apr 23, 16:00
193.75
+0.65
(+0.34%)
After-Hours: 20:00
Biogen Free Cash Flow (Quarterly): -52.70M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -52.70M |
| September 30, 2023 | 504.80M |
| June 30, 2023 | 400.00M |
| March 31, 2023 | 383.70M |
| December 31, 2022 | -262.40M |
| September 30, 2022 | 601.90M |
| June 30, 2022 | 697.70M |
| March 31, 2022 | 103.90M |
| December 31, 2021 | 769.80M |
| September 30, 2021 | 743.40M |
| June 30, 2021 | 1.155B |
| March 31, 2021 | 676.40M |
| December 31, 2020 | -468.10M |
| September 30, 2020 | 1.097B |
| June 30, 2020 | 1.844B |
| March 31, 2020 | 1.206B |
| December 31, 2019 | 1.695B |
| September 30, 2019 | 1.605B |
| June 30, 2019 | 1.777B |
| March 31, 2019 | 1.332B |
| December 31, 2018 | 1.670B |
| September 30, 2018 | 1.545B |
| June 30, 2018 | 834.50M |
| March 31, 2018 | 1.252B |
| December 31, 2017 | 1.223B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.349B |
| June 30, 2017 | 846.40M |
| March 31, 2017 | -830.00M |
| December 31, 2016 | 1.399B |
| September 30, 2016 | 710.60M |
| June 30, 2016 | 890.00M |
| March 31, 2016 | 860.30M |
| December 31, 2015 | 1.048B |
| September 30, 2015 | 659.90M |
| June 30, 2015 | 917.40M |
| March 31, 2015 | 635.20M |
| December 31, 2014 | 797.70M |
| September 30, 2014 | 851.49M |
| June 30, 2014 | 926.59M |
| March 31, 2014 | 50.32M |
| December 31, 2013 | 790.37M |
| September 30, 2013 | 591.73M |
| June 30, 2013 | -2.692B |
| March 31, 2013 | 145.65M |
| December 31, 2012 | 438.87M |
| September 30, 2012 | 483.72M |
| June 30, 2012 | 562.68M |
| March 31, 2012 | 140.07M |
| December 31, 2011 | 403.53M |
| September 30, 2011 | 519.17M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-468.10M
Minimum
Dec 2020
1.844B
Maximum
Jun 2020
761.93M
Average
697.70M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly and Co | -1.963B |
| Bristol-Myers Squibb Co | 3.922B |
| Gilead Sciences Inc | 1.954B |
| AbbVie Inc | 4.548B |
| Regeneron Pharmaceuticals Inc | 776.20M |